Cited by 1,291Genetic Neurodegenerative DiseasesPrion Diseases and Protein MisfoldingGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo

Open access

Scherzinger, Eberhard, Lurz, Rudi, Turmaine, Mark, Mangiarini, Laura, Hollenbach, Birgit, Hasenbank, Renate, Bates, Gillian P, Davies, Stephen W, Lehrach, Hans, Wanker, Erich E·1997·Cell

DOI 10.1016/s0092-8674(00)80514-0

Open this paper in CoChat — free account Open PDF

Abstract

The mechanism by which an elongated polyglutamine sequence causes neurodegeneration in Huntington's disease (HD) is unknown. In this study, we show that the proteolytic cleavage of a GST-huntingtin fusion protein leads to the formation of insoluble high molecular weight protein aggregates only when the polyglutamine expansion is in the pathogenic range. Electron micrographs of these aggregates revealed a fibrillar or ribbon-like morphology, reminiscent of scrapie prions and beta-amyloid fibrils in Alzheimer's disease. Subcellular fractionation and ultrastructural techniques showed the in vivo presence of these structures in the brains of mice transgenic for the HD mutation. Our in vitro model will aid in an eventual understanding of the molecular pathology of HD and the development of preventative strategies.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)80514-0

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citation
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188
Self-citation
Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
Perutz, M. F., Johnson, T., Suzuki, M., & Finch, J. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5355 · Cited by 1,060
Scrapie prions aggregate to form amyloid-like birefringent rods
Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Bendheim, P. E., Groth, D., & Glenner, G. G. (1983) · Cell · doi:10.1016/0092-8674(83)90168-x · Cited by 1,052

Show all 42 references

Research works printed but not linked: 2

Harper, P.S. (1991). Huntington's disease, Edition 22. P.S. Harper, ed. (London: W.B. Saunders Co., Ltd).
Roizin, 1979, Neuronal nuclear-cytoplasmic changes in Huntington's chorea, Adv. Neurol., 23, 95

Sorted by citations

Items 801–900 of 998

When repetita no-longer iuvant: somatic instability of the CAG triplet in Huntington’s disease
Cattaneo, E. F., Scalzo, D., Zobel, M., Iennaco, R., Maffezzini, C., Besusso, D., & Maestri, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1204 · Cited by 20
Computational investigation of molecular mechanism and neuropathological implications in Huntington disease
Gopalakrishnan, C., Kalsi, N., Jethi, S., & Purohit, R. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2462-7 · Cited by 18
Conformational Diseases: Structural Studies of Aggregation of Polyglutamine Proteins
Papaleo, E., & Invernizzi, G. (2010) · Current Computer - Aided Drug Design · doi:10.2174/157340911793743574 · Cited by 18
“In fact, proteins involved in polyQ diseases, such as huntingtin, ataxins and atrophin-1 have the distinctive feature to be triggered in their pathological form by the expansion of the polyQ stretch [27-29].”
Background
Comparative Characterization of Short Monomeric Polyglutamine Peptides by Replica Exchange Molecular Dynamics Simulation
Nakano, M., Watanabe, H., Rothstein, S. M., & Tanaka, S. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp9122024 · Cited by 18
Discovery of Arginine Ethyl Ester as Polyglutamine Aggregation Inhibitor: Conformational Transitioning of Huntingtin N-Terminus Augments Aggregation Suppression
Singh, V. P., Patel, K. A., Sharma, R. K., Patil, P. R., Joshi, A. S., Parihar, R., Athilingam, T., Sinha, N., Ganesh, S., Sinha, P., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00167 · Cited by 18
Neurodegenerative disease-associated protein aggregates are poor inducers of the heat shock response in neuronal cells
Gil, R. S., Cox, D., McAlary, L., Berg, T., Walker, A. K., Yerbury, J. J., Ooi, L., & Ecroyd, H. W. (2020) · Journal of Cell Science · doi:10.1242/jcs.243709 · Cited by 18
“Interestingly, in vitro, mutant SOD1, α-synuclein, and Htt (Scherzinger et al., 1997) are β-sheet forming, amyloidogenic proteins, whereas Fluc forms amorphous aggregates (Gupta et al.”
Background
Site‐Specific Phosphorylation of Huntingtin Exon 1 Recombinant Proteins Enabled by the Discovery of Novel Kinases
Chiki, A., Ricci, J., Hegde, R. N., Abriata, L. A., Reif, A., Boudeffa, D., & Lashuel, H. A. (2020) · ChemBioChem · doi:10.1002/cbic.202000508 · Cited by 18
An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During Aging
Pigazzini, M. L., Lawrenz, M., Margineanu, A., Schierle, G. S. K., & Kirstein, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.721749 · Cited by 20
Molecular Dynamics Simulations Applied to Structural and Dynamical Transitions of the Huntingtin Protein: A Review
Moldovean‐Cioroianu, N. S., & Chiş, V. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00561 · Cited by 18
Aggregate formation and the impairment of long‐term synaptic facilitation by ectopic expression of mutant huntingtin in Aplysia neurons
Lee, J., Lim, C., Lee, S., Kim, H., Nukina, N., & Kaang, B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01650.x · Cited by 18
Molecular genetics of the hereditary ataxias.
Pandolfo, M., & Montermini, L. (1998) · Advances in Genetics · doi:10.1016/s0065-2660(08)60141-8 · Cited by 14
SIAH proteins regulate the degradation and intra‐mitochondrial aggregation of PINK1 : Implications for mitochondrial pathology in Parkinson's disease
Elghani, F. A., Safory, H., Hamza, H., Savyon, M., Farhoud, M., Toren-Hershkoviz, M., Vitic, Z., Ebanks, K., Shani, V., Bisharat, S., et al. (2022) · Aging Cell · doi:10.1111/acel.13731 · Cited by 16
SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells
Elias, A. K., Scanlon, D. B., Musgrave, I., & Carver, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.06.006 · Cited by 17
On the Design of Broad Based Screening Assays to Identify Potential Pharmacological Chaperones of Protein Misfolding Diseases
Naik, S., Zhang, N., Gao, P., & Fisher, M. T. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611212220006 · Cited by 19
Brain-specific factors in combination with mutant huntingtin induce gene-specific transcriptional dysregulation
Gomez, G. T., Hu, H., McCaw, E. A., & Denovan‐Wright, E. M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.12.004 · Cited by 17
Optimization of trans-Splicing for Huntington's Disease RNA Therapy
Rindt, H., Tom, C. M., Lorson, C. L., & Mattis, V. B. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00544 · Cited by 18
“…(Steffan et al., 2004; Gu et al., 2009; O’Rourke et al., 2013; Vicente Miranda et al., 2016), buildup of toxic aggregates (DiFiglia et al., 1997; Scherzinger et al., 1997) or soluble mtHTT oligomers (Takahashi et al., 2008; Leitman et al., 2013; Ramdzan et al., 2017), and haploinsufficiency of…”
Background
Divalproex sodium modulates nuclear localization of ataxin‐3 and prevents cellular toxicity caused by expanded ataxin‐3
Wang, Z., Hanet, A., Weishäupl, D., Martins, I., Sowa, A., Riess, O., & Schmidt, T. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12795 · Cited by 14
Amyloids of multiple species: are they helpful in survival?
Upadhyay, A., & Mishra, A. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12399 · Cited by 17
“CAG repeats-containing huntingtin (Htt) protein also shows typical amyloidic features as observed in postmortem brains of Huntington’s disease (HD) patients as well as in mouse models of the disease (Scherzinger et al., 1997; Ghahghaei & Faridi, 2009).”
Background
Shock and awe: unleashing the heat shock response to treat Huntington disease
Jackrel, M. E., & Shorter, J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59190 · Cited by 17
Confocal Fluorescence Detected Linear Dichroism Imaging of Isolated Human Amyloid Fibrils. Role of Supercoiling
Steinbach, G., Pomozi, I., Jánosa, D. P., Makovitzky, J., & Garab, G. (2010) · Journal of Fluorescence · doi:10.1007/s10895-010-0684-3 · Cited by 17
“The slides were prepared as described earlier [38, 39].”
Method
Chaperone-like N-Methyl Peptide Inhibitors of Polyglutamine Aggregation
Lanning, J. D., Hawk, A. J., Derryberry, J., & Meredith, S. C. (2010) · Biochemistry · doi:10.1021/bi1006095 · Cited by 17
“1 of huntingtin protein expands beyond a threshold of approximately 35 residues (1), leading to polyQ aggregation (2-4).”
Background
A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal huntingtin’s polyglutamine stretch on CAG140 mouse model pathogenesis
Zheng, S., Ghitani, N., Blackburn, J. S., Liu, J.-P., & Zeitlin, S. O. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-28 · Cited by 17
“To confirm that normal htt was sequestered in mutant htt inclusions, we first performed cellulose acetate filter trap assays [34] with the initial 800xg pellet fraction from 24 month-old Hdh whole brain extracts (containing crude nuclei and insoluble htt aggregates) (Figure 9A).”
Method
The hnRNP-Htt axis regulates necrotic cell death induced by transcriptional repression through impaired RNA splicing
Mao, Y., Tamura, T., Yuki, Y., Abe, D., Tamada, Y., Imoto, S., Tanaka, H., Homma, H., Tagawa, K., Miyano, S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.101 · Cited by 17
Ocular Findings in Spinocerebellar Ataxia 7
McLaughlin, M. E., & Dryja, T. P. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.5.655 · Cited by 17
Folding and Fibril Formation of the Cell Cycle Protein Cks1
Bader, R., Seeliger, M. A., Kelly, S. E., Ilag, L. L., Meersman, F., Limones, A., Luisi, B. F., Dobson, C. M., & Itzhaki, L. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603628200 · Cited by 17
Preventing polyglutamine-induced activation of c-Jun delays neuronal dysfunction in a mouse model of SCA7 retinopathy
Mérienne, K., Friedman, J. S., Akimoto, M., Sleymane, G. A., Weber, C., Swaroop, A., & Trottier, Y. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.002 · Cited by 18
“This expansion results in a longer polyQ-track, which in turn leads to toxic gain-of-function and increased propensity of the expanded protein to aggregate (Scherzinger et al., 1997; Ross and Poirier, 2004).”
Background
The role of pre‐existing aggregates in Hsp104‐dependent polyglutamine aggregate formation and epigenetic change of yeast prions
Kimura, Y., Koitabashi, S., Kakizuka, A., & Fujita, T. (2004) · Genes to Cells · doi:10.1111/j.1356-9597.2004.00759.x · Cited by 17
“…ykimura@rinshoken.or.jp Genes to Cells (2004) 9, 685–696 © Blackwell Publishing Limited686 PolyQ also spontaneously changes from the soluble state into amyloid-like aggregates in a polyQ length and in a concentration-dependent manner in vitro (Ross et al. 2003; Scherzinger et al. 1997, 1999).”
Background
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington?s disease
Zucker, B., Ludin, D., Gerds, T. A., L�cking, C. H., Landwehrmeyer, G. B., & Feuerstein, T. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0959-9 · Cited by 17
Protein Aggregate Characterization in Models of Neurodegenerative Disease
Tebbenkamp, A. T. N., & Borchelt, D. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-562-6_6 · Cited by 17
Current Understanding of Protein Aggregation in Neurodegenerative Diseases
Hu, C., Lin, M., Wang, C., & Zhang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110568 · Cited by 21
Cholesterol impacts the formation of huntingtin/lipid complexes and subsequent aggregation
Stonebraker, A. R., Beasley, M. A., Massinople, S. E., Wunder, M. M., Li, P., Valentine, S. J., & Legleiter, J. A. (2023) · Protein Science · doi:10.1002/pro.4642 · Cited by 16
“…a threshold of 35 repeats (Penney et al., 1997; Snell et al., 1993) results in the aggregation of htt into amyloid-like fibrils (Chen et al., 2002; Scherzinger et al., 1997, 1999) through a complex pathway that involves additional aggregate species including oligomers and amorphous aggregates…”
Background
Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans
Wu, Y., Chen, Y., Yu, X., Zhang, M., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010443 · Cited by 18
“A hallmark pathological feature of HD is the deposit of intranuclear and cytoplasmic aggregates, with previous evidence found in post-mortem human HD brains, transgenic mouse models and in vitro cell culture models [60,61].”
Background
The Effect of Protein Fusions on the Production and Mechanical Properties of Protein‐Based Materials
Tsai, S., Howell, D. W., Huang, Z., Hsiao, H., Lü, Y., Matthews, K. S., Lou, J., & Bondos, S. E. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201402997 · Cited by 16
Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures
Trepte, P., Strempel, N. U., & Wanker, E. E. (2014) · Essays in Biochemistry · doi:10.1042/bse0560167 · Cited by 17
“IBs, which generally have a diameter of 1–5 μm, are predominantly detected in cortical and striatal neurons [14,16].”
BackgroundResultInfluentialSelf-citation
SRCP1 Conveys Resistance to Polyglutamine Aggregation
Santarriaga, S., Haver, H. N., Kanack, A. J., Fikejs, A. S., Sison, S. L., Egner, J. M., Bostrom, J. R., Seminary, E. R., Hill, R. B., Link, B. A., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.008 · Cited by 15
Harmine Acts as an Indirect Inhibitor of Intracellular Protein Aggregation
Jain, S., Panuganti, V., Jha, S., & Roy, I. (2020) · ACS Omega · doi:10.1021/acsomega.9b02375 · Cited by 16
Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
Wang, S., Tatman, M., & Monteiro, M. J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01039-9 · Cited by 15
Huntington's disease
Bonelli, R. M., & Beal, M. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00030-9 · Cited by 16
Neurobiological Applications of Small Molecule Screening
Bauer, A. J., & Stockwell, B. R. (2008) · Chemical Reviews · doi:10.1021/cr0782372 · Cited by 16
Study of the aggregation mechanism of polyglutamine peptides using replica exchange molecular dynamics simulations
Nakano, M., Ebina, K., & Tanaka, S. (2013) · Journal of Molecular Modeling · doi:10.1007/s00894-012-1712-9 · Cited by 16
An Engineered Viral Protease Exhibiting Substrate Specificity for a Polyglutamine Stretch Prevents Polyglutamine-Induced Neuronal Cell Death
Sellamuthu, S., Shin, B. H., Han, H.-E., Park, S. M., Oh, H. J., Rho, S., Lee, Y. J., & Park, W. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022554 · Cited by 16
“The aggregation of polyglutamine (polyQ) proteins within neuronal cells has been implicated in the pathogenesis of a group of neurodegenerative disorders, including Huntington’s disease (HD) [1,2].”
Background
Nuclear aggregation of huntingtin is not prevented by deletion of chaperone Hsp104
Cao, F., Levine, J. J., Li, S., & Li, X. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00068-0 · Cited by 16
Conformational variability of the intracellular domain of Drosophila Notch and its interaction with Suppressor of Hairless
Kelly, D. F., Lake, R. J., Walz, T., & Artavanis‐Tsakonas, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702887104 · Cited by 16
Structures of CUG Repeats in RNA
Pinheiro, P., Scarlett, G. P., Rodger, A., Rodger, P. M., Murray, A., Brown, T., Newbury, S. F., & McClellan, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202235200 · Cited by 16
Pathogenic Polyglutamine Tracts Are Potent Inducers of Spontaneous Sup35 and Rnq1 Amyloidogenesis
Goehler, H., Dröge, A., Lurz, R., Schnoegl, S., Chernoff, Y. O., & Wanker, E. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009642 · Cited by 16
“The polyclonal antibodies anti-polyQ (anti-CAG53b), antiSup35 and anti-Rnq1 have been described elsewhere [18,37,40]; the anti-His antibody was purchased from Qiagen.”
BackgroundMethodSelf-citation
Development of novel therapies for Huntington's disease: hope and challenge1
Qin, Z., Wang, J., & Gu, Z. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00520.x · Cited by 16
Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model
Shing, K., Sapp, E., Boudi, A., Liu, S., Seeley, C., Marchionini, D. M., DiFiglia, M., & Kegel-Gleason, K. B. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106313 · Cited by 14
Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation
van der Wel, P. C. A. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230731 · Cited by 15
PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model
Carnemolla, A., Michelazzi, S., & Agostoni, E. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00121 · Cited by 15
“The encoded mutant huntingtin (mHTT) has the propensity to misfold and aggregate (Scherzinger et al., 1997; Gutekunst et al., 1999), producing a whole spectrum of oligomeric species ultimately merging into cellular aggregates and intranuclear inclusions, a major pathological hallmark of HD.”
Background
Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington’s Disease Monkey pluripotent stem cells
Goodnight, A., Kremsky, I., Khampang, S., Jung, Y. H., Billingsley, J. M., Bosinger, S. E., Corces, V. G., & Chan, A. W. S. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0313-6 · Cited by 15
Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background
Strong, M. K., Southwell, A. L., Yonan, J. M., Hayden, M. R., MacGregor, G. R., Thompson, L. M., & Steward, O. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-129005 · Cited by 15
“The assay was performed as described [40].”
Histochemical and topo-optical investigations on tissue-isolated andin vitroamyloid fibrils
Appel, T. R., Richter, S., LINKE, R. P., & Makovitzky, J. (2005) · Amyloid · doi:10.1080/13506120500221906 · Cited by 15
“Preparation of suitable specimens [10] from tissue-isolated and in vitro amyloid-like fibrils.”
BackgroundMethodInfluential
Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset
Sugaya, K., Matsubara, S., Kagamihara, Y., Kawata, A., & Hayashi, H. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000635 · Cited by 15
“In many of these conditions, protein deposition involves the formation of amyloid fibrils, and polyQ aggregates show many of the attributes of amyloid [7], [8].”
Background
Orthogonal Cross-Seeding: An Approach To Explore Protein Aggregates In Living Cells
Hinz, J., Gierasch, L. M., & Ignatova, Z. (2008) · Biochemistry · doi:10.1021/bi800002j · Cited by 15
“35 glutamines, and the polyQ-dependent disease risk and tendency to aggregate are recapitulated both in Vitro and in cell culture (31).”
Background
Exploiting Yeast Genetics to Inform Therapeutic Strategies for Huntington’s Disease
Giorgini, F., & Muchowski, P. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-540-4_9 · Cited by 15
Noncoding RNAs in protein clearance pathways: implications in neurodegenerative diseases
Sengupta, S. (2017) · Journal of Genetics · doi:10.1007/s12041-017-0747-1 · Cited by 15
Animal Models of Neurodegenerative Diseases
Phillips, W., Michell, A. W., Pruess, H., & Barker, R. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-931-4_10 · Cited by 15
Huntington's and other polyglutamine diseases: many effects of single gene mutations
Luthi‐Carter, R. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.10.002 · Cited by 14
Advances in Huntington’s disease: implications for experimental therapeutics
Feigin, A. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199808000-00012 · Cited by 15
Polyglutamine Aggregation in Huntington and Related Diseases
Polling, S., Hill, A. F., & Hatters, D. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5434-2_8 · Cited by 15
The Possible Structural Models for Polyglutamine Aggregation: A Molecular Dynamics Simulations Study
Zhou, Z.-L., Zhao, J.-H., Liu, H., Wu, J. W., Liu, K.-T., Chuang, C., Tsai, W., & Ho, Y. (2011) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2011.10508603 · Cited by 14
An accurate model of polyglutamine
Digambaranath, J. L., Campbell, T. V., Chung, A., McPhail, M. J., Stevenson, K. E., Zohdy, M. A., & Finke, J. M. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22970 · Cited by 14
Nanopipettes as a Potential Diagnostic Tool for Selective Nanopore Detection of Biomolecules
Kuanaeva, R. M., Vaneev, A. N., Gorelkin, P. V., & Erofeev, A. S. (2024) · Biosensors · doi:10.3390/bios14120627 · Cited by 15
“…diseases include disorders in which abnormal proteins can accumulate intranuclearly, such as polyglutamine in Huntington’s disease [121] and spinocerebellar ataxia [122]; disorders characterized by cytoplasmic inclusions, such as α -synuclein in Parkinson’s disease [123];…”
Identification of an RNA Polymerase III Regulator Linked to Disease-Associated Protein Aggregation
Sin, O., de Jong, T. V., Mata‐Cabana, A., Kudron, M. M., Zaini, M. A., Aprile, F. A., Seinstra, R. I., Stroo, E., Prins, R. W., Martineau, C. N., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.022 · Cited by 15
“To establish whether MOAG-2/LIR-3 promoted aggregation of SDS-insoluble polyglutamine aggregates, we performed a filter retardation assay on lysates of wild-type and moag-2/lir-3 mutant polyglutamine worms (Scherzinger et al., 1997; Wanker et al., 1999).”
MethodSelf-citation
Molecular Mechanism of Stabilizing the Helical Structure of Huntingtin N17 in a Micellar Environment
Zhang, L., Kang, H., Vázquez, F. X., Toledo, L. M., Luan, B., & Zhou, R. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b01476 · Cited by 14
Thermal unfolding of human lysozyme induces aggregation: Recognition of the aggregates by antisera against the native protein
Alam, M. T., Rizvi, A., Rauf, M. A., Owais, M., & Naeem, A. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.095 · Cited by 14
Comparative functional analysis of proteins containing low-complexity predicted amyloid regions
Kumari, B., Kumar, R., Chauhan, V., & Kumar, M. (2018) · PeerJ · doi:10.7717/peerj.5823 · Cited by 14
“Many studies demonstrated that amyloids are commonly formed in Gln and/or Asn rich domains (Scherzinger et al., 1997; Warrick et al., 1998; Chow, Paulson & Bottomley, 2004).”
Background
Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT
Chongtham, A., Bornemann, D. J., Barbaro, B. A., Lukácsovich, T., Agrawal, N., Syed, A., Worthge, S. A., Purcell, J. M., Burke, J., Chin, T. M., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa001 · Cited by 14
A High-Throughput Small Molecule Screen for C. elegans Linker Cell Death Inhibitors
Schwendeman, A. R., & Shaham, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164595 · Cited by 14
Synthesis and Application of Aurophilic Poly(Cysteine) and Poly(Cysteine)-Containing Copolymers
Ulkoski, D., & Scholz, C. (2017) · Polymers · doi:10.3390/polym9100500 · Cited by 14
“, extended sequences of p(L-Glutamine) associated with Huntington’s disease [1,2] and poly(L-Alanine) sequences indicated in oculopharyngeal muscular dystrophy [3].”
Background
Glial expression of disease-associated poly-glutamine proteins impairs the blood–brain barrier in Drosophila
Yeh, P.-A., Liu, Y., Chu, W.-C., Liu, J., & Sun, Y. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy160 · Cited by 15
Human ubiquitin-like proteins as central coordinators in autophagy
Mohan, J., & Wollert, T. (2018) · Interface Focus · doi:10.1098/rsfs.2018.0025 · Cited by 15
The conformational ensemble of the disordered and aggregation-protective 182–291 region of ataxin-3
Invernizzi, G., Lambrughi, M., Regonesi, M. E., Tortora, P., & Papaleo, E. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.07.007 · Cited by 14
Anti‐oligomeric single chain variable domain antibody differentially affects huntingtin and α‐synuclein aggregates
Nannenga, B. L., Zameer, A., & Sierks, M. R. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.014 · Cited by 14
“coli DH-5a cells were grown, protein expression was induced, and protein purified from cell extract using glutathione agarose beads essentially as described [13].”
BackgroundMethodInfluential
Molecular Biology of Huntington's Disease (HD) and HD-Like Disorders
Rubinsztein, D. C. (2003) · Elsevier eBooks · doi:10.1016/b978-012566652-7/50035-6 · Cited by 14
FOXR1 regulates stress response pathways and is necessary for proper brain development
Mota, A., Waxman, H. K., Hong, R., Lagani, G. D., Niu, S.-Y., Bertherat, F., Wolfe, L. A., Malicdan, C. M., Markello, T. C., Adams, D. R., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009854 · Cited by 13
Structural Determinants of Polyglutamine Protofibrils and Crystallites
Man, V. H., Roland, C., & Sagui, C. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500358g · Cited by 13
Transcription Factor Sequestration by Polyglutamine Proteins
Yamanaka, T., & Nukina, N. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-756-3_14 · Cited by 13
An apparent core/shell architecture of polyQ aggregates in the aging Caenorhabditis elegans neuron
Fisher, R. S., Jimenez, R. M., Soto, E., Kalev, D., & Elbaum‐Garfinkle, S. (2021) · Protein Science · doi:10.1002/pro.4105 · Cited by 8
Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington’s Disease Knock-in Mice
Schindler, F., Praedel, N., Neuendorf, N., Kunz, S., Schnoegl, S., Mason, M. A., Taxy, B. A., Bates, G., Khoshnan, A., Priller, J., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.682172 · Cited by 11
“…obtained that N-terminal mHTT exon-1 (mHTTex1) fragments spontaneously self-assemble into stable β-sheet fibrillar structures in vitro and in vivo (Scherzinger et al., 1997, 1999; Waelter et al., 2001) and are also able to spread from cell to cell (Babcock and Ganetzky, 2015; Maxan et al., 2020).”
BackgroundSelf-citation
Effect of charged amino acid side chain length on lateral cross-strand interactions between carboxylate- and guanidinium-containing residues in a β-hairpin
Kuo, H., Liu, S.-L., Chiu, W.-C., Fang, C.-J., Chang, H.-C., Wang, W.-R., Yang, P.-A., Li, J.-H., Huang, S., Huang, S., et al. (2015) · Amino Acids · doi:10.1007/s00726-015-1916-2 · Cited by 13
“2007), Huntington’s disease (Scherzinger et al. 1997; Truant et al. 2008), Parkinson’s disease (Irvine et al.”
Background
Location Trumps Length: Polyglutamine-Mediated Changes in Folding and Aggregation of a Host Protein
Tobelmann, M. D., & Murphy, R. M. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.04.028 · Cited by 13
Self-Assembly of the Synthetic Polymer (Leu-Glu)n: An Amyloid-like Structure Formation
Moses, J. P., Satheeshkumar, K., Murali, J., Alli, D., & Rajadas, J. (2003) · Langmuir · doi:10.1021/la026661m · Cited by 13
Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones
Kubota, H., Kitamura, A., & Nagata, K. (2010) · Methods · doi:10.1016/j.ymeth.2010.12.035 · Cited by 12
Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases
Sugaya, K., & Matsubara, S. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-29 · Cited by 13
“The polyQ length dependence of disease onset correlates strongly with the tendency of expanded polyQ proteins to aggregate in disease models [14,15].”
Background
Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection
Kokona, B., May, C. A., Cunningham, N. R., Richmond, L., Garcia, F. J., Durante, J. C., Ulrich, K., Roberts, C. M., Link, C. D., Stafford, W. F., et al. (2015) · Protein Science · doi:10.1002/pro.2854 · Cited by 13
Fluorescence Anisotropy Uncovers Changes in Protein Packing with Inclusion Growth in a Cellular Model of Polyglutamine Aggregation
Bhardwaj, V., Panicker, M. M., & Udgaonkar, J. B. (2014) · Biochemistry · doi:10.1021/bi500383h · Cited by 13
“(3) Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., and Wanker, E. E. (1997) Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.”
Effect of Charged Amino Acid Side Chain Length on Lateral Cross-Strand Interactions between Carboxylate-Containing Residues and Lysine Analogues in a β-Hairpin
Kuo, H., Fang, C.-J., Tsai, H., Yang, M.-F., Chang, H.-C., Liu, S.-L., Kuo, L.-H., Wang, W.-R., Yang, P.-A., Huang, S., et al. (2013) · Biochemistry · doi:10.1021/bi400974x · Cited by 13
Huntington’s Disease Pathogenesis: Mechanisms and Pathways
Spada, A. R. L., Weydt, P., & Pineda, V. V. (2011) · Europe PMC (PubMed Central) · Cited by 13
The Kinetics, Thermodynamics and Mechanisms of Short Aromatic Peptide Self-Assembly
Mason, T. O., & Buell, A. K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9791-2_3 · Cited by 14
High-Throughput and High-Content Screening for Huntington's Disease Therapeutics
Varma, H., Lo, D. C., & Stockwell, B. R. (2010) · Frontiers in neuroscience · doi:10.1201/ebk0849390005-c5 · Cited by 13
Optimization of a Polyglutamine Aggregation Inhibitor Peptide (QBP1) Using a Thioflavin T Fluorescence Assay
Hamuro, L., Zhang, G., Tucker, T. J., Self, C. R., Strittmatter, W. J., & Burke, J. R. (2007) · Assay and Drug Development Technologies · doi:10.1089/adt.2007.083 · Cited by 13
Hprt (CAG)146 mice: Age of onset of behavioral abnormalities, time course of neuronal intranuclear inclusion accumulation, neurotransmitter marker alterations, mitochondrial function markers, and susceptibility to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
Tallaksen‐Greene, S. J., Ordway, J. M., Crouse, A. B., Jackson, W. S., Detloff, P. J., & Albin, R. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10855 · Cited by 13
“…pathology, e.g., Lewy bodies and amyloid plaques, NIIs and cytoplasmic inclusions are suggested to be proximate causes of neurodegeneration in CAG repeat disorders (Davies et al., 1997; Ross, 1997, 2002; Scherzinger et al., 1997; Becher et al., 1998; Sisodia, 1998; Trojanowski and Lee, 2000).”
Robust cell-free expression of sub-pathological and pathological huntingtin Exon-1 for NMR studies. General approaches for the isotopic labeling of low-complexity proteins
Morató, A., Elena-Real, C. A., Popovic, M., Fournet, A., Zhang, K., Allemand, F., Sibille, N., Urbanek, A., & Bernadó, P. (2020) · Biomolecules · doi:10.3390/biom10101458 · Cited by 12
“The N-terminal domain, preceding the poly-Q tract, is composed of 17 residues (N17) and has been shown to enhance the aggregation of poly-Q tracts in vitro and in vivo [14,15].”
Background
Towards Standardizing Nomenclature in Huntington’s Disease Research
DiFiglia, M., Leavitt, B. R., Macdonald, D., & Thompson, L. M. (2024) · Journal of Huntington s Disease · doi:10.3233/jhd-240044 · Cited by 12
Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Reif, A., Chiki, A., Ricci, J., & Lashuel, H. A. (2018) · Journal of Visualized Experiments · doi:10.3791/57506 · Cited by 12
Moonlighting glyceraldehyde-3-phosphate dehydrogenase (GAPDH) modulates protein aggregation
Chaudhary, S., Dhiman, A., Patidar, A., Malhotra, H., Talukdar, S., Dilawari, R., Chaubey, G. K., Modanwal, R., Raje, C. I., & Raje, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166202 · Cited by 12
Use of yeast as a system to study amyloid toxicity
Summers, D. W., & Cyr, D. (2010) · Methods · doi:10.1016/j.ymeth.2010.11.007 · Cited by 12
Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
Kumar, H., & Udgaonkar, J. B. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.04.004 · Cited by 12
The Nature, Extent, and Consequences of Genetic Variation in the opa Repeats of Notch in Drosophila
Rice, C., Beekman, D., Liu, L.-P., & Erives, A. J. (2015) · G3: Genes, Genomes, Genetics · doi:10.1534/g3.115.021659 · Cited by 16
“Polyglutamine-rich factors have a tendency to aggregate (Scherzinger et al. 1997, 1999; Chen et al. 2002) but, morespeci ﬁ cally,theymaydosothroughthePerutzpolarzipper(Perutz et al. 1993, 1994).”

Authors: Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E.
Affiliations: Max Planck Institute for Molecular Genetics (DE)
University College London (GB)
Guy's Hospital (GB)
Corresponding author: Wanker, Erich E
ORCID: Bates, Gillian P
Wanker, Erich E
Venue: Cell
Publisher: Elsevier BV
Published: 1997-08
Volume: 90
Issue: 3
Pages: 549-558
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)80514-0
OpenAlex: W2079250951
Cited by: 1,291
References: 42
Citations by year: 2026: 17 · 2025: 31 · 2024: 23 · 2023: 23 · 2022: 24 · 2021: 37 · 2020: 55 · 2019: 44 · 2018: 49 · 2017: 43 · 2016: 34 · 2015: 32 · 2014: 43 · 2013: 38 · 2012: 52
FWCI: 25.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5829 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords: Huntington's disease, polyglutamine expansion, huntingtin, protein aggregation, amyloid-like aggregates, proteolytic cleavage, GST fusion protein, neurodegeneration, transgenic mouse model, fibril morphology, amyloid-beta
MeSH terms: Huntingtin Protein, Amino Acid Sequence, Amyloid, Animals, Base Sequence, Brain, Cell Nucleus, Exons, Glutathione Transferase, Humans, Huntington Disease, Kidney, Mice, Transgenic, Molecular Sequence Data, Nerve Tissue Proteins, Nuclear Proteins, Recombinant Fusion Proteins, Polymerase Chain Reaction, DNA Primers, Macromolecular Substances, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks